IL133397A - Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin - Google Patents

Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin

Info

Publication number
IL133397A
IL133397A IL13339798A IL13339798A IL133397A IL 133397 A IL133397 A IL 133397A IL 13339798 A IL13339798 A IL 13339798A IL 13339798 A IL13339798 A IL 13339798A IL 133397 A IL133397 A IL 133397A
Authority
IL
Israel
Prior art keywords
cyclodextrin
pharmaceutical compositions
oral administration
active substance
family
Prior art date
Application number
IL13339798A
Other languages
English (en)
Other versions
IL133397A0 (en
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3890611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL133397(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of IL133397A0 publication Critical patent/IL133397A0/xx
Publication of IL133397A publication Critical patent/IL133397A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13339798A 1997-07-03 1998-07-02 Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin IL133397A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9700572A BE1011251A3 (fr) 1997-07-03 1997-07-03 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
PCT/BE1998/000100 WO1999001133A1 (fr) 1997-07-03 1998-07-02 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine

Publications (2)

Publication Number Publication Date
IL133397A0 IL133397A0 (en) 2001-04-30
IL133397A true IL133397A (en) 2005-07-25

Family

ID=3890611

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13339798A IL133397A (en) 1997-07-03 1998-07-02 Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin

Country Status (20)

Country Link
US (1) US6455533B1 (de)
EP (1) EP0994710B2 (de)
JP (2) JP2002508773A (de)
KR (1) KR100551510B1 (de)
CN (1) CN1150900C (de)
AT (1) ATE224717T1 (de)
AU (1) AU727140B2 (de)
BE (1) BE1011251A3 (de)
BR (1) BR9810495A (de)
CA (1) CA2294783C (de)
DE (1) DE69808297T3 (de)
DK (1) DK0994710T4 (de)
ES (1) ES2184293T5 (de)
ID (1) ID23806A (de)
IL (1) IL133397A (de)
NZ (1) NZ501820A (de)
PL (1) PL192348B1 (de)
PT (1) PT994710E (de)
RU (1) RU2192863C2 (de)
WO (1) WO1999001133A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
NZ528047A (en) * 2001-02-05 2006-03-31 Scherer Technologies Inc R P Methods and compositions for masking the taste of pharmaceutically active agents
CN101632642B (zh) * 2002-01-15 2011-06-08 Ucb法奇姆股份有限公司 口感和稳定性改善的配方
ATE388693T1 (de) * 2002-04-04 2008-03-15 Pfizer Prod Inc Wohlschmeckende kautablette
MX2007000759A (es) * 2004-07-22 2007-03-28 Pfizer Prod Inc Formulacion de enmascaramiento del sabor que comprende el farmaco en una forma de disolucion retardada y/o ciclodextrina en una forma de disolucion mejorada.
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
US20070086974A1 (en) * 2005-10-06 2007-04-19 Gawande Rahul S Cetirizine compositions
US20090269393A1 (en) * 2006-06-12 2009-10-29 Jubliant Organosys Limited Chewable Bilayer Tablet Formulation
JP2008143807A (ja) * 2006-12-07 2008-06-26 Sato Pharmaceutical Co Ltd 感冒薬カプセル剤及びその製造方法
WO2009006898A1 (en) * 2007-07-11 2009-01-15 Fertin Pharma A/S Stable medicated chewing gum comprising cyclodextrin inclusion complex
WO2009006899A1 (en) * 2007-07-11 2009-01-15 Fertin Pharma A/S Compressed chewing gum tablet comprising taste-masking agent
WO2009054432A1 (ja) * 2007-10-26 2009-04-30 Daiichi Sankyo Company, Limited 口腔内速崩壊性医薬組成物およびその製造方法
US8138192B2 (en) * 2007-10-31 2012-03-20 Genebiology, Inc. Injectable meclizine formulations and methods
US20090137606A1 (en) * 2007-11-06 2009-05-28 Rakefet Cohen Chewable formulations
ES2564056T3 (es) * 2008-09-05 2016-03-17 Johnson & Johnson Consumer Inc. Método para hacer pastillas de cetirizina
WO2011110939A2 (en) 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
HK1161509A2 (en) * 2010-06-04 2012-07-27 全球药物科技有限公司 Oral meclizine aqueous formulations with taste flavoring agent
CN101905027A (zh) * 2010-07-27 2010-12-08 北京华禧联合科技发展有限公司 含米格列奈钙和环糊精的口服药用组合物
SG188509A1 (en) 2010-09-13 2013-04-30 Bev Rx Inc Aqueous drug delivery system comprising off - flavor masking agent
US9945862B2 (en) 2011-06-03 2018-04-17 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
RU2589833C2 (ru) * 2013-12-12 2016-07-10 Общество С Ограниченной Ответственностью "Фарма Старт" Твердая лекарственная форма препарата седативного и снотворного действия
EP3122330B1 (de) * 2014-03-27 2018-07-25 Ucb Farchim, S.A. Pharmazeutische zusammensetzungen beinhaltend levocetirizin
HRP20221047T1 (hr) 2014-08-28 2022-11-11 Eisai R&D Management Co., Ltd. Derivat kinolina visoke čistoće i postupak za njegovu proizvodnju
HUE064614T2 (hu) 2015-02-25 2024-04-28 Eisai R&D Man Co Ltd Eljárás egy kinolin-származék keserû ízének elnyomására
CA2978226C (en) 2015-03-04 2025-02-18 Eisai R&D Management Co., Ltd. COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR/FGFR/RET TYROSINE KINASE INHIBITOR TO TREAT CANCER
BR112017027227B1 (pt) 2015-06-16 2023-12-12 Eisai R&D Management Co., Ltd Agente anti-câncer
MX381976B (es) 2015-08-20 2025-03-13 Eisai R&D Man Co Ltd Agente terapéutico contra tumores.
KR102539920B1 (ko) 2017-02-08 2023-06-05 에자이 알앤드디 매니지먼트 가부시키가이샤 종양-치료용 약제학적 조성물
RU2019134940A (ru) 2017-05-16 2021-06-16 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Лечение гепатоцеллюлярной карциномы
KR102110304B1 (ko) * 2017-06-30 2020-05-14 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성 및 복약순응도가 향상된 복합 츄어블정 및 그 제조방법
EP4099977A1 (de) * 2020-02-03 2022-12-14 Johnson & Johnson Consumer Inc. Einschichtige kautablette mit cetirizin
WO2022106923A1 (en) 2020-11-18 2022-05-27 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
JPS58177949A (ja) * 1982-04-12 1983-10-18 Takeda Chem Ind Ltd ランカシジン群抗生物質包接化合物
JPS60204712A (ja) * 1984-03-29 1985-10-16 Ss Pharmaceut Co Ltd 塩酸メクリジンの安定化液状組成物
JPS63243031A (ja) † 1987-03-28 1988-10-07 Tokyo Tanabe Co Ltd 胆汁酸の固形製剤
FR2647343B1 (fr) 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
EP0950412A3 (de) † 1992-09-24 2001-05-16 Sepracor, Inc. Zusammensetzungen zur Behandlung von allergischen Krankheiten unter Verwendung von (-) Cetirizin
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
KR960706490A (ko) * 1993-12-01 1996-12-09 헤르베르트 서키· 헤르베르트 루프 치환된 아미노알킬아미노피리딘(substituted aminoalkylaminopyridines)
US5866179A (en) 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
MX2007000759A (es) * 2004-07-22 2007-03-28 Pfizer Prod Inc Formulacion de enmascaramiento del sabor que comprende el farmaco en una forma de disolucion retardada y/o ciclodextrina en una forma de disolucion mejorada.

Also Published As

Publication number Publication date
AU8201598A (en) 1999-01-25
ATE224717T1 (de) 2002-10-15
DE69808297D1 (de) 2002-10-31
CN1261799A (zh) 2000-08-02
DE69808297T3 (de) 2006-01-19
US20020032217A1 (en) 2002-03-14
DK0994710T4 (da) 2005-10-17
PL192348B1 (pl) 2006-10-31
EP0994710B1 (de) 2002-09-25
BE1011251A3 (fr) 1999-06-01
CN1150900C (zh) 2004-05-26
IL133397A0 (en) 2001-04-30
PT994710E (pt) 2003-02-28
KR20010014398A (ko) 2001-02-26
JP2002508773A (ja) 2002-03-19
ES2184293T5 (es) 2006-01-16
BR9810495A (pt) 2000-09-12
KR100551510B1 (ko) 2006-02-13
JP2007091760A (ja) 2007-04-12
RU2192863C2 (ru) 2002-11-20
EP0994710B2 (de) 2005-09-21
CA2294783C (fr) 2006-11-14
WO1999001133A1 (fr) 1999-01-14
NZ501820A (en) 2000-10-27
AU727140B2 (en) 2000-12-07
HK1029060A1 (en) 2001-03-23
EP0994710A1 (de) 2000-04-26
US6455533B1 (en) 2002-09-24
CA2294783A1 (fr) 1999-01-14
ID23806A (id) 2000-05-11
ES2184293T3 (es) 2003-04-01
DK0994710T3 (da) 2003-01-20
PL337794A1 (en) 2000-09-11
DE69808297T2 (de) 2003-04-17

Similar Documents

Publication Publication Date Title
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
BG106030A (en) Pharmaceutical composition
MY118151A (en) Pharmaceutical formulations containing voriconazole.
PL347671A1 (en) Compounds and compositions for delivering active agents
BR0015188A (pt) Composições farmacêuticas
GEP20053473B (en) High Potency Dihydroergotamine Compositions
AU2274201A (en) Compounds and compositions for delivering active agents
AP9901534A0 (en) Pharmaceutical formulations.
AU2845599A (en) Pharmaceutical compositions and their use
ZA200007299B (en) Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol.
MXPA02001631A (es) Composiciones farmaceuticas para administracion oral y topica.
PL346764A1 (en) New oral formulation for 5-ht4
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
AU3580995A (en) Derivatives of carbohydrates and compositions containing them
EP1273301A3 (de) Pharmazeutische Zubereitungen, Wirkstoffe enthaltend, die sich für unerlaubte Verabreichung bieten
GEP20043377B (en) Pharmaceutical Complex
MD1473F2 (en) Antiherpetic remedy
AU2502301A (en) Medicament and combination of compatible medicaments
PL346939A1 (en) Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues
TW429144B (en) The pharmaceutical composition comprising the Con.A-Maltose complex and vehicle for oral use
ZA9810886B (en) Compositions for nasal administration.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees